Filter by
Filter by
Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma
A health-economic study by the Jacksonville group. This study utilized (1) patient-level dosimetric information for a cost-effectiveness analysis using a Markov...
Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma
Using Excess Absolute Risk (EAR) models, this study compared the risk of secondary cancer for Hodgkin lymphoma survivors after either IMRT or PBT radiation...
Proton theraphy for adults with mediastinal lymphomas: The international lymphoma radiation oncology group (ILROG) guidelines.
Radiation treatment techniques that increase the excess radiation dose to organs at risk (OARs) puts patients at risk of increased side effects, especially late...